Insider Trading & Ownership - ELMS STEVE

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ELMS STEVE
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-18
Sale
2024-03-19
9:48 pm
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
461,716$6.0724$2,803,7412,192,112
(Indirect
Direct)
View
2024-03-13
Sale
2024-03-15
9:00 pm
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
1,038,284$6.1057$6,339,4182,653,828
(Indirect
Direct)
View
2021-06-29
Purchase
2021-07-01
6:29 pm
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
187,500$16$3,000,0002,834,910
(Direct)
View
2021-03-16
Purchase
2021-03-18
4:35 pm
Marker Therapeutics Inc.MRKRELMS STEVE
Director
1,142,857$1.75$2,000,0003,159,879
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-13
Option Award
2024-06-17
4:26 pm
N/A
2034-06-12
Elevation Oncology Inc.ELEVELMS STEVE
Director
35,000$035,000
(Indirect)
View
2024-02-26
Option Award
2024-02-28
9:00 pm
N/A
2034-03-26
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
61,581$03,729,653
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:09 pm
N/A
2033-06-15
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
31,238$031,238
(Indirect)
View
2023-06-06
Option Award
2023-06-08
9:32 pm
N/A
2033-06-05
Marker Therapeutics Inc.MRKRELMS STEVE
Director
8,000$08,000
(Direct)
View
2023-03-06
Option Award
2023-03-08
9:30 pm
N/A
2033-03-06
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
77,445$03,719,702
(Direct)
View
2022-06-17
Option Award
2022-06-22
6:43 pm
N/A
2032-06-16
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
15,619$015,619
(Indirect)
View
2022-05-24
Option Award
2022-05-26
4:09 pm
N/A
2032-05-23
Marker Therapeutics Inc.MRKRELMS STEVE
Director
80,000$080,000
(Direct)
View
2022-03-07
Option Award
2022-03-09
5:59 pm
N/A
2032-03-07
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
79,758$03,695,429
(Direct)
View
2021-06-29
Conversion
2021-07-01
6:29 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
12,288,426$02,834,910
(Direct)
View
2021-06-24
Option Award
2021-06-28
6:18 pm
N/A
2031-06-23
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
31,238$031,238
(Indirect)
View

Ownership
2021-06-24
6:32 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
ELMS STEVE
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
10% Owner
0$02,647,410
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:38 pm
N/A
2031-06-09
Zosano Pharma CorpZSANELMS STEVE
Director
45,000$02,770,726
(Direct)
View
2021-06-08
Option Award
2021-06-10
6:55 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
12,658$03,172,537
(Direct)
View
2021-02-25
Option Award
2021-03-01
9:02 pm
N/A
2031-02-25
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
55,000$055,000
(Direct)
View

Ownership
2021-02-12
5:12 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
0$02,017,022
(Indirect)
View
2020-05-19
Ownership
2021-02-12
5:12 pm
N/A
N/A
Marker Therapeutics Inc.MRKRELMS STEVE
Director
17,022$02,017,022
(Direct)
View
2020-06-25
Option Award
2020-06-29
9:47 pm
N/A
N/A
Zosano Pharma CorpZSANELMS STEVE
Director
7,500$02,725,766
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:10 pm
N/A
2030-06-02
Zosano Pharma CorpZSANELMS STEVE
Director
15,000$015,000
(Direct)
View
2020-02-28
Option Award(A)
2020-05-01
5:12 pm
N/A
N/A
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
7,500$07,500
(Direct)
View
2020-02-28
Option Award
2020-03-03
7:11 pm
N/A
2030-02-28
ADMA BIOLOGICS INC.ADMAELMS STEVE
Director
22,500$022,500
(Direct)
View
2019-12-02
Option Award
2019-12-06
10:23 am
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
Aisling Capital Partners IV LP
Aisling Capital Partners IV LLC
ELMS STEVE
SCHIFF ANDREW N
10% Owner
689,655$1.452,718,226
(Direct)
View
(A) Indicate amendment filing.